Expansion of toxSYN Platform with Best-in-Class Linker Payloads Based on Validated Topiosomerase 1 Inhibitor (Exatecap) & DNA-damaging Agent (Calicheamicin)

Time: 4:15 pm
day: day 1- pm


  • Demonstrating how SYNtecan E™ and SYNeamicin G™ linker-payloads show excellent in vivo efficacy and tolerability
  • Immunogenic cell-death driven by SYNtecan E™ ADCs corroborated in syngeneic mouse models
  • Discussing how a comprehensive set of linker-payloads enables matching of payload MOA to any clinical indication